Emma Cummins

403 total citations
6 papers, 202 citations indexed

About

Emma Cummins is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Emma Cummins has authored 6 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Emma Cummins's work include Monoclonal and Polyclonal Antibodies Research (4 papers), T-cell and B-cell Immunology (2 papers) and Peptidase Inhibition and Analysis (2 papers). Emma Cummins is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), T-cell and B-cell Immunology (2 papers) and Peptidase Inhibition and Analysis (2 papers). Emma Cummins collaborates with scholars based in Ireland, Canada and United States. Emma Cummins's co-authors include Ismael Samudio, Thomas Kislinger, Davinder Gill, Brian J. Fennell, Orla Cunningham, Janet Paulsen, William J.J. Finlay, Matthew Lambert, Lioudmila Tchistiakova and Laird Bloom and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Emma Cummins

5 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Cummins Ireland	5	130	113	56	24	17	6	202
Adriana Kita United States	6	261 2.0×	182 1.6×	49 0.9×	25 1.0×	30 1.8×	7	357
Jin Lü China	9	162 1.2×	93 0.8×	62 1.1×	25 1.0×	13 0.8×	24	298
Patricia Siguenza United States	5	131 1.0×	157 1.4×	56 1.0×	92 3.8×	13 0.8×	8	224
Marija Vilaj Croatia	9	240 1.8×	116 1.0×	135 2.4×	8 0.3×	20 1.2×	11	294
Ju Liu China	8	131 1.0×	88 0.8×	196 3.5×	18 0.8×	19 1.1×	12	343
Molly Hunter United States	4	176 1.4×	100 0.9×	36 0.6×	24 1.0×	6 0.4×	7	228
Marie‐Claude Djidja United Kingdom	6	204 1.6×	81 0.7×	71 1.3×	17 0.7×	177 10.4×	6	322
Kai Zheng China	4	304 2.3×	240 2.1×	73 1.3×	21 0.9×	35 2.1×	5	348
Regula B. Buser Switzerland	7	141 1.1×	144 1.3×	99 1.8×	46 1.9×	4 0.2×	7	336
Dror Baran Israel	7	208 1.6×	128 1.1×	60 1.1×	26 1.1×	3 0.2×	10	280

Countries citing papers authored by Emma Cummins

Since Specialization

Citations

This map shows the geographic impact of Emma Cummins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Cummins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Cummins more than expected).

Fields of papers citing papers by Emma Cummins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Cummins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Cummins. The network helps show where Emma Cummins may publish in the future.

Co-authorship network of co-authors of Emma Cummins

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Cummins. A scholar is included among the top collaborators of Emma Cummins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Cummins. Emma Cummins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kulić, Iva, et al.. (2024). Abstract 6028: Preferential tumor-to-normal tissue biodistribution and single-dose efficacy with ABD147, a DLL3-targeted engineered antibody-based radiotherapeutic, in preclinical small cell lung cancer models. Cancer Research. 84(6_Supplement). 6028–6028.

2.

Kovaleva, Marina, Jiquan Zhang, John Steven, et al.. (2018). Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. Journal of Immunology Research. 2018. 1–13. 11 indexed citations

3.

Cummins, Emma, et al.. (2018). Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics. 15(3). 259–275. 55 indexed citations

4.

Wu, Leeying, Matthew Lambert, Brian J. Fennell, et al.. (2011). Fundamental Characteristics of the Immunoglobulin VH Repertoire of Chickens in Comparison with Those of Humans, Mice, and Camelids. The Journal of Immunology. 188(1). 322–333. 70 indexed citations

5.

Finlay, William J.J., Orla Cunningham, Matthew Lambert, et al.. (2009). Affinity Maturation of a Humanized Rat Antibody for Anti-RAGE Therapy: Comprehensive Mutagenesis Reveals a High Level of Mutational Plasticity Both Inside and Outside the Complementarity-Determining Regions. Journal of Molecular Biology. 388(3). 541–558. 50 indexed citations

6.

Cummins, Emma, Deborah Luxenberg, Fionnuala McAleese, et al.. (2008). A simple high-throughput purification method for hit identification in protein screening. Journal of Immunological Methods. 339(1). 38–46. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact